Search

everythinglearnresearchcommunity

for

Search:↓

Roxithromycin, an antibiotic, can increase hair growth and might be used as a treatment for hair loss.

Melatonin receptors in hair follicles help regulate hair growth and could treat hair loss.

Activating the Nrf2 pathway reduces inflammation and cell activation in human hair follicles, suggesting a potential treatment for certain hair loss conditions.

A new method helps isolate key hair components to study hair growth and loss.

Women with hair loss have more androgen receptors in certain hair follicles.

iNOS contributes to hair loss in obese diabetic mice and blocking it may encourage hair growth.

Regenerative medicine may help reduce radiotherapy side effects like skin cancer, fibrosis, pain, and hair loss.

Clinical signs of hyperandrogenism are related to female pattern hair loss severity, but biochemical markers are not.

Hair loss in men may be caused by inflammation triggered by hormones, and treatments reducing inflammation could potentially promote hair growth.

GRK2 is essential for healthy hair follicle function, and its absence can lead to hair loss and cysts.

Trichoscopic features help diagnose and assess female pattern hair loss severity, with inflammation playing a key role.

Low ferritin and Vitamin D levels may cause hair loss after COVID-19.

The mTOR signaling pathway is crucial for hair health and targeting it may lead to new hair loss treatments.

A substance called Cell-free fat extract can effectively treat common hair loss by increasing hair growth and density.

Different genes cause Female Pattern Hair Loss compared to male hair loss, and treatments vary, but more research is needed to understand it fully.

Men with a family history of hair loss on their mother's side are more likely to have female pattern hair loss.

Women's hair loss can be due to hormonal changes and various conditions, with treatments focusing on stopping progression and managing symptoms.

Claudin-1 and Claudin-3 are crucial for keeping hair follicle structure and preventing a type of hair loss called telogen effluvium.

Teriflunomide often causes mild to moderate hair thinning and loss in MS patients, which usually improves with or without treatment.

Hair casts are often mistaken for head lice, scalp pain in hair loss is linked to certain nerve factors, eyelash growth treatment is safe and effective, and nail shedding in children may follow hand-foot-mouth disease.

A device was made in 2008 to measure hair loss severity. Other findings include: frizzy mutation in mice isn't related to Fgfr2, C/EBPx marks preadipocytes, Cyclosporin A speeds up hair growth in mice, blocking plasmin and metalloproteinases hinders healing, hyperbaric oxygen helps ischemic wound healing, amniotic membranes heal wounds better than polyurethane foam, rhVEGF165 from a fibrin matrix improves tissue flap viability and induces VEGF-R2 expression, and bFGF enhances wound healing and reduces scarring in rabbits.

Topical minoxidil is the best-supported treatment for female hair loss, but personalized plans are needed.

Oxidative stress may worsen female pattern hair loss and could help track the disease and treatment.

All three shampoos reduced dandruff and hair loss, but ketoconazole and piroctone olamine also made hair thicker.

Different hair fiber development might explain why hair loss severity varies in patients with a specific genetic mutation, and treatments that thicken hair could help.

A woman's hair loss worsened after starting hepatitis C treatment due to immune changes in her hair follicles.

No benefits found using platelet-rich plasma in hair transplants for male hair loss.

Human scalp hair follicles can produce hormones and have a system similar to a brain-body communication network.

Some supplements may help with hair loss, but there's not enough strong evidence to recommend them without doctor advice.

The document concludes that there are various causes and treatments for hair loss, with hair transplantation being a notable option.